15th Nov 2013 17:16
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a revaluation of the cash element of the notional investment held within the GSK 401K plan (The Plan), which is notionally held in GSK American Depositary Shares (ADSs), the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned Persons on 15 November 2013 of the following increase in the notional allocation of ADSs on 14 November 2013 at a price of $52.13 per ADS:-
Director/PDMR
|
Number of ADSs |
Connected Person |
Number of ADSs | ||
Dr M M Slaoui
|
13 |
Dr K Slaoui |
11 | ||
Mr W C Louv
| 19 | - | - | ||
Mrs D P Connelly
| 2 | - | - | ||
|
| ||||
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
Sonja Arsenić
Corporate Secretariat
15 November 2013
Related Shares:
Glaxosmithkline